Abstract:Thermal 3D printing has gained substantial attention in pharmaceutical formulation, especially concerning its potential use in personalized dose delivery. The choice of a printable polymer is crucial in this technique, but it is restricted due to technical issues such as thermal stability and thermal-rheological properties of the polymers. Polyethylene oxide (PEO) is a widely used polymer in drug formulation designs, with potential application in 3D printing due to its favourable rheological properties.  However, the thermal stability of PEOs exposed to high temperatures during FDM needs to be characterized. This research focused on the characterization of two molecular weights of PEO (7M and 0.9M) under various manufacturing methods and formulation compositions. PEO was mixed with other low-viscosity polymers of hydroxypropyl cellulose (HPC) or ethyl cellulose (EC) to achieve printable formulations (PEO/HPC or PEO/EC). Tablets were manufactured by direct compression, compression of hot-melt extrudates, HME, (at 150 oC), or by FDM 3D-printing FDM (at 220 oC). Differential scanning calorimetry (DSC), X-ray powder diffraction (XRPD), gel permeation chromatography (GPC), and dissolution tests and their kinetics studies were carried out. Results showed that thermal processes could reduce the crystallinity of PEO and induce some molecular weight reduction that varies depending on the Mw of PEO. As a result, dissolution efficiency (DE%) was influenced depending on the formulation composition and the method of manufacturing. For formulations containing PEO and HPC, 3D printed and HME tablets showed higher DE (>60%) compared to directly compressed tablets (DE<50%), while for those with PEO and EC, 3D printing reduced DE% to <26% compared to direct compression (~30%) and HME tablets (~50%). This was attributed to the hydrophobic nature of EC and the increased hardness of the printed tablets, preventing tablet disintegration during dissolution which outweighs the molecular weight reduction in PEO.

Effects of Lyophilization on the Release Profiles of 3D Printed Delivery Systems Fabricated with Carboxymethyl Cellulose Hydrogel

Three-Dimensional Electrohydrodynamic Printing and Spinning of Flexible Composite Structures for Oral Multidrug Forms

3D printing of extended-release tablets of theophylline using hydroxypropyl methylcellulose (HPMC) hydrogels

3D Printing Technology Based on Versatile Gelatin-Carrageenan Gel System for Drug Formulations

Novel On-Demand 3-Dimensional (3-D) Printed Tablets Using Fill Density as an Effective Release-Controlling Tool

Development of Ph-Responsive Polypills Via Semi-Solid Extrusion 3D Printing.

Three-Dimensional Printing of PVA Capsular Devices for Applications in Compounding Pharmacy: Effect of Design Parameters on Pharmaceutical Performance

Printability of a Cellulose Derivative for Extrusion-Based 3D Printing: The Application on a Biodegradable Support Material

An integrated manufacturing strategy to fabricate delivery system using gelatin/alginate hybrid hydrogels: 3D printing and freeze-drying

Preparation of chitosan-hyaluronic acid microcapsules and its dynamic release behavior analysis in a 3D-printed microchannel system: Exploration and verification

3D Printing of Bioinspired Compartmentalized Capsular Structure for Controlled Drug Release

Structure-Based Gastro-Retentive and Controlled-Release Drug Delivery with Novel 3D Printing

Fabrication of 3D printed mutable drug delivery devices: a comparative study of volumetric and digital light processing printing

Structure-function correlation and personalized 3D printed tablets using a quality by design (QbD) approach

Preparation of High-Drug-Loaded Clarithromycin Gastric-Floating Sustained-Release Tablets Using 3D Printing

Formulation and characterization of an interpenetrating network hydrogel of locust bean gum and cellulose microfibrils for 3D printing

Programming of Multicomponent Temporal Release Profiles in 3D Printed Polypills via Core–Shell, Multilayer, and Gradient Concentration Profiles

The effect of manufacturing method on polymer stability and drug release from PEO matrix tablets: A comparison among three methods; physical mixture, hot melt extrusion, and 3D printing

Veering to a Continuous Platform of Fused Deposition Modeling Based 3D Printing for Pharmaceutical Dosage Forms: Understanding the Effect of Layer Orientation on Formulation Performance

The Development of Hypromellose Based Semisolid 3D Printing Inks for Drug Delivery

3D Printed Polyvinyl Alcohol Tablets with Multiple Release Profiles